Signalling pathways in pemphigus vulgaris

被引:10
|
作者
Li, Xiaoguang
Ishii, Norito
Ohata, Chika
Furumura, Minao
Hashimoto, Takashi [1 ]
机构
[1] Kurume Univ, Dept Dermatol, Sch Med, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan
关键词
acantholysis; pemphigus vulgaris; signalling pathway; DESMOGLEIN; 3; C-MYC; P38MAPK; DISEASE; PLAKOGLOBIN; INDUCTION; IGG; INHIBITION; DISRUPTION; ACTIVATION;
D O I
10.1111/exd.12317
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Acantholysis in pemphigus vulgaris is induced by binding of autoantibodies to desmoglein 3 (Dsg3). The roles of signalling pathways on development of acantholysis have recently been extensively studied. In the study by Sayar et al., recently published in Exp Dermatol, epidermal growth factor receptor (EGFR) signalling was activated in both in vivo and in vitro pemphigus vulgaris experimental models. However, while EGFR inhibitors suppressed activity of p38 mitogen-activated protein kinase (p38MAPK) linearly, they suppressed activity of c-Myc and acantholysis in a non-linear, V-shaped relationship. These findings indicated complicated interactions among EGFR, p38MAPK and c-Myc in pemphigus vulgaris pathology.
引用
收藏
页码:155 / 156
页数:2
相关论文
共 50 条
  • [1] Critical appraisal of different triggering pathways for the pathobiology of pemphigus vulgaris-A review
    Hannh, R.
    Ramani, Pratibha
    Tilakaratne, W. M.
    Sukumaran, Gheena
    Ramasubramanian, Abilasha
    Krishnan, Reshma Poothakulath
    ORAL DISEASES, 2022, 28 (07) : 1760 - 1769
  • [2] Ocular surface involvement in pemphigus vulgaris: An interdisciplinary review
    Memar, Omeed
    Jabbehdari, Sayena
    Caughlin, Benjamin
    Djalilian, Ali R.
    OCULAR SURFACE, 2020, 18 (01) : 40 - 46
  • [3] Phosphorylated p38 mitogen-activated kinase in patients with pemphigus vulgaris: a case-controlled study
    Sobeih, Shereen
    Saleh, Marwah
    Kholoussi, Shams
    El Khateeb, Eman
    Kadry, Dina
    JOURNAL OF EGYPTIAN WOMENS DERMATOLOGICAL SOCIETY, 2020, 17 (01): : 31 - 37
  • [4] Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris
    Gliem, Martin
    Heupel, Wolfgang-Moritz
    Spindler, Volker
    Harms, Gregory S.
    Waschke, Jens
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2010, 299 (03): : C606 - C613
  • [5] Diagnosis and Clinical Features of Pemphigus Vulgaris
    Venugopal, Supriya S.
    Murrell, Dedee F.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2012, 32 (02) : 233 - +
  • [6] Apoptosis is not required for acantholysis in pemphigus vulgaris
    Schmidt, Enno
    Gutberlet, Judith
    Siegmund, Daniela
    Berg, Daniela
    Wajant, Harald
    Waschke, Jens
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 296 (01): : C162 - C172
  • [7] Diagnosis and Clinical Features of Pemphigus Vulgaris
    Venugopal, Supriya S.
    Murrell, Dedee F.
    DERMATOLOGIC CLINICS, 2011, 29 (03) : 373 - +
  • [8] Oral Pemphigus Vulgaris
    Subadra, K.
    Sathasivasubramanian, S.
    Warrier, Aravind S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [9] Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering
    Spindler, Volker
    Roetzer, Vera
    Dehner, Carina
    Kempf, Bettina
    Gliem, Martin
    Radeva, Mariya
    Hartlieb, Eva
    Harms, Gregory S.
    Schmidt, Enno
    Waschke, Jens
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (02) : 800 - 811
  • [10] Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis
    Grando, Sergei A.
    Bystryn, Jean-Claude
    Chernyavsky, Alexander I.
    Frusic-Zlotkin, Marina
    Gniadecki, Robert
    Lotti, Roberta
    Milner, Yoram
    Pittelkow, Mark R.
    Pincelli, Carlo
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (09) : 764 - 770